Fundraising FoxLife Sciences Greenhouse Investments — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Biolattice Ophthalmics, Inc.biolatticetech.comMar 2026
BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants.
BiotechHealthtechMedical DevicesPhiladelphia, US
Linda Alunkal(Executive Officer, Director)Amelia Zellander(Executive Officer, Director)in
BoardGregory Jackson(Director)
Co-investorsRobin Hood VenturesSOSV
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.